Lipedema Landmines: How MCAS, hEDS, and POTS Show Up and Affect Lipedema Treatment - Karen Ashforth

MCAS (#MastCellActivationSyndrome), hEDS (Hypermobile #EhlersDanlosSyndrome), and POTS (#PosturalOrthostaticTachycardiaSyndrome) are “landmines” that can show up and impact treatment for #lipedema patients. In this webinar, Karen Ashforth focuses on increasing awareness of these three syndromes that can confound and complicate lipedema. ABOUT OUR SPEAKER: Karen Ashforth, MS, OTR/L, CLT-LANA, has practiced as an occupational therapist for over 40 years. Specializing as a board-certified hand therapist led to her interest and specialization of treating lymphedema and fibrosis 20 years ago. Karen’s passions in lymphedema practice are equipment innovation and development, treatment of underlying fibrosis and inflammation, and assessment of complex and difficult cases. She is considered an expert in the clinical use of pneumatic compression and has participated in the development of numerous devices and appliances. She has outpatient lymphedema practices at St. Joseph’s Medical Center in Stockton, California, and Dominican Rehabilitation in Santa Cruz, California, as well as a private telehealth and consulting practice. Karen speaks frequently at academic, clinical, and professional settings and performs clinical research that she presents and publishes nationally and internationally. She is also an adjunct faculty member with the University of the Pacific in the Doctoral Physical Therapy Program. MORE INFORMATION This webinar is presented by Lympha Press, makers of the Optimal Plus, as part of our Lympha Press Education Series. Learn more about Lympha Press and our advanced pneumatic compression therapy here: Register for our upcoming webinars here: